Bio-Techne Corporation
TECH
$55.89
-$1.96-3.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.25% | -9.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.25% | -9.59% | |||
| Cost of Revenue | 6.56% | -8.93% | |||
| Gross Profit | 1.58% | -9.93% | |||
| SG&A Expenses | -4.85% | 76.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.21% | 17.96% | |||
| Operating Income | 20.30% | -57.95% | |||
| Income Before Tax | 5.82% | 309.94% | |||
| Income Tax Expenses | 30.28% | 289.27% | |||
| Earnings from Continuing Operations | -0.46% | 316.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.46% | 316.00% | |||
| EBIT | 20.30% | -57.95% | |||
| EBITDA | 14.01% | -48.85% | |||
| EPS Basic | -0.69% | 314.87% | |||
| Normalized Basic EPS | 11.70% | -58.41% | |||
| EPS Diluted | 0.00% | 306.36% | |||
| Normalized Diluted EPS | 11.45% | -58.42% | |||
| Average Basic Shares Outstanding | 0.24% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.41% | 0.39% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.01% | 1.47% | |||